Hydroxycarbamide (INN BAN) or hydroxyurea (USAN AAN. Brand names include Hydrea and Droxia) is an antineoplastic drug first synthesized in 1869 used in myeloproliferative disorders specifically polycythemia vera and essential thrombocythemia.
This page contains content from the copyrighted Wikipedia article "Hydroxycarbamide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.